These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 20048396

  • 21. Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry.
    Ortolani P, Balducelli M, Marzaroli P, Piovaccari G, Menozzi A, Guiducci V, Sangiorgio P, Tarantino F, Geraci G, Castriota F, Tondi S, Saia F, Cooke RM, Guastaroba P, Grilli R, Marzocchi A, Maresta A.
    Circulation; 2008 Feb 19; 117(7):923-30. PubMed ID: 18250265
    [Abstract] [Full Text] [Related]

  • 22. Long term results of unprotected left main percutaneous coronary intervention with DES versus BMS.
    Capodanno D, Di Salvo ME, Capranzano P, Seminara D, Caggegi A, Barrano G, Tamburino C.
    Minerva Cardioangiol; 2009 Feb 19; 57(1):1-6. PubMed ID: 19202514
    [Abstract] [Full Text] [Related]

  • 23. Early and mid-term results of drug-eluting stent implantation in unprotected left main.
    Chieffo A, Stankovic G, Bonizzoni E, Tsagalou E, Iakovou I, Montorfano M, Airoldi F, Michev I, Sangiorgi MG, Carlino M, Vitrella G, Colombo A.
    Circulation; 2005 Feb 15; 111(6):791-5. PubMed ID: 15699254
    [Abstract] [Full Text] [Related]

  • 24. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
    Steinberg DH, Gaglia MA, Pinto Slottow TL, Roy P, Bonello L, De Labriolle A, Lemesle G, Torguson R, Kineshige K, Xue Z, Suddath WO, Kent KM, Satler LF, Pichard AD, Lindsay J, Waksman R.
    Am J Cardiol; 2009 Feb 15; 103(4):491-5. PubMed ID: 19195508
    [Abstract] [Full Text] [Related]

  • 25. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L, Chen LL, Lin CG, Peng YF, Zheng XC, Luo YK, Zhang FL, Chen JH, Yan XP, Huang ZR.
    Chin Med J (Engl); 2008 Aug 20; 121(16):1518-23. PubMed ID: 18982862
    [Abstract] [Full Text] [Related]

  • 26. Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention.
    Roy P, Buch AN, Javaid A, Okabe T, Raya V, Pinto Slottow TL, Steinberg DH, Smith K, Xue Z, Gevorkian N, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R.
    Am J Cardiol; 2008 Feb 01; 101(3):293-9. PubMed ID: 18237587
    [Abstract] [Full Text] [Related]

  • 27. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].
    Silber S, Herdeg C.
    Herz; 2008 Apr 01; 33(3):196-205. PubMed ID: 18568314
    [Abstract] [Full Text] [Related]

  • 28. Two-year clinical outcome after successful implantation of drug-eluting and bare metal stents in diabetic patients: results from a real-world single center registry.
    Dou KF, Xu B, Yang YJ, Chen JL, Qiao SB, Li JJ, Qin XW, Liu HB, Wu YJ, Chen J, Yao M, You SJ, Yuan JQ, Dai J, Gao RL.
    Chin Med J (Engl); 2009 Mar 20; 122(6):612-6. PubMed ID: 19323921
    [Abstract] [Full Text] [Related]

  • 29. Clinical outcomes following drug-eluting versus bare metal stent implantation for lesion subsets excluded from pivotal clinical trials: findings from the GHOST Study (Guthrie Health System Off-Label StenT Study).
    Harjai KJ, Orshaw P, Shenoy C, Acharji S, Sporn D, Aboufares A, Stapleton D.
    J Interv Cardiol; 2008 Aug 20; 21(4):315-24. PubMed ID: 18754967
    [Abstract] [Full Text] [Related]

  • 30. Late outcomes after drug-eluting stent implantation in "real-world" clinical practice.
    Ramsdale DR, Rao A, Asghar O, Ramsdale KA, McKay E.
    J Invasive Cardiol; 2008 Oct 20; 20(10):493-500. PubMed ID: 18829991
    [Abstract] [Full Text] [Related]

  • 31. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
    Ajani AE, Yan BP, Clark DJ, Eccleston D, Walton A, Lew R, Meehan A, Brennan A, Reid C, Duffy SJ, Melbourne Interventional Group (MIG) Investigators.
    Heart Lung Circ; 2007 Aug 20; 16(4):269-73. PubMed ID: 17419097
    [Abstract] [Full Text] [Related]

  • 32. Long-term outcome after bare-metal or drug-eluting stenting for allograft coronary artery disease.
    Beygui F, Varnous S, Montalescot G, Fernandez F, Collet JP, Leprince P, Le Feuvre C, Pavie A, Komajda M, Metzger JP, Gandjbakhch I.
    J Heart Lung Transplant; 2010 Mar 20; 29(3):316-22. PubMed ID: 19837605
    [Abstract] [Full Text] [Related]

  • 33. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
    Fineschi M, Gori T, Pierli C, Casini S, Sinicropi G, Buti A, Del Pasqua A, Bravi A.
    Can J Cardiol; 2005 Dec 20; 21(14):1281-5. PubMed ID: 16341297
    [Abstract] [Full Text] [Related]

  • 34. Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation.
    Jeong YH, Hong MK, Lee CW, Park DW, Kim YH, Kim JJ, Park SW, Park SJ.
    Int J Cardiol; 2008 Mar 28; 125(1):36-40. PubMed ID: 17521753
    [Abstract] [Full Text] [Related]

  • 35. Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents.
    Kim YH, Park DW, Lee SW, Yun SC, Lee CW, Hong MK, Park SW, Seung KB, Gwon HC, Jeong MH, Jang Y, Kim HS, Seong IW, Park HS, Ahn T, Chae IH, Tahk SJ, Chung WS, Park SJ, Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization Investigators.
    Circulation; 2009 Aug 04; 120(5):400-7. PubMed ID: 19620506
    [Abstract] [Full Text] [Related]

  • 36. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization.
    Das P, Moliterno DJ, Charnigo R, Mukherjee D, Steinhubl SR, Sneed JD, Booth DC, Ziada KM.
    J Invasive Cardiol; 2006 Sep 04; 18(9):405-8. PubMed ID: 16954577
    [Abstract] [Full Text] [Related]

  • 37. Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry.
    Williams DO, Abbott JD, Kip KE, DEScover Investigators.
    Circulation; 2006 Nov 14; 114(20):2154-62. PubMed ID: 17060386
    [Abstract] [Full Text] [Related]

  • 38. Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry.
    Tamburino C, Di Salvo ME, Capodanno D, Marzocchi A, Sheiban I, Margheri M, Maresta A, Barlocco F, Sangiorgi G, Piovaccari G, Bartorelli A, Briguori C, Ardissino D, Di Pede F, Ramondo A, Inglese L, Petronio AS, Bolognese L, Benassi A, Palmieri C, Patti A, De Servi S.
    Eur Heart J; 2009 May 14; 30(10):1171-9. PubMed ID: 19276194
    [Abstract] [Full Text] [Related]

  • 39. Stent-related cardiac events after non-cardiac surgery: drug-eluting stent vs. bare metal stent.
    Kim HL, Park KW, Kwak JJ, Kim YS, Sir JJ, Lee SJ, Lee HY, Chang HJ, Kang HJ, Cho YS, Chung WY, Chae IH, Choi DJ, Kim HS, Oh BH, Park YB, Koo BK.
    Int J Cardiol; 2008 Jan 24; 123(3):353-4. PubMed ID: 17346821
    [Abstract] [Full Text] [Related]

  • 40. Safety and effectiveness of drug-eluting stents among diabetic patients: a propensity analysis.
    Ko DT, Chiu M, Austin PC, Bowen J, Cohen EA, Tu JV.
    Am Heart J; 2008 Jul 24; 156(1):125-34. PubMed ID: 18585507
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.